Holocene Advisors, LP Alkermes Plc. Transaction History

Holocene Advisors, LP

$38 Billion
Q2 2025

A detailed history of Holocene Advisors, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Holocene Advisors, LP holds 2,853,768 shares of ALKS stock, worth $79.5 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,853,768

Previous 2,174,602 31.23%

Holding current value

$79.5 Million

Previous $71.8 Million 13.71%

% of portfolio

0.21%

Previous 0.23%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$26.59 - $32.65 $18.1 Million - $22.2 Million	679,166 Added 31.23%	2,853,768 $81.6 Million
Q1 2025 May 15, 2025	BUY	$28.08 - $36.0 $53.8 Million - $69 Million	1,916,699 Added 743.19%	2,174,602 $71.8 Million
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $6.63 Million - $8.11 Million	257,903 New	257,903 $7.42 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $42.8 Million - $50.8 Million	-1,509,196 Reduced 54.64%	1,252,953 $39.2 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $3.05 Million - $3.5 Million	120,573 Added 4.56%	2,762,149 $77.9 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $4.49 Million - $5.36 Million	204,439 Added 8.39%	2,641,576 $69 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $10.6 Million - $15.3 Million	481,630 Added 24.63%	2,437,137 $54.4 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $16.3 Million - $18.9 Million	-618,017 Reduced 24.01%	1,955,507 $58.3 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $9.03 Million - $11 Million	-391,268 Reduced 13.2%	2,573,524 $67.7 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $8.8 Million - $13.1 Million	409,816 Added 16.04%	2,964,792 $69 Million
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $8.13 Million - $11.2 Million	347,979 Added 15.77%	2,554,976 $78.8 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $41.4 Million - $55.5 Million	2,206,997 New	2,206,997 $54.1 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $157,291 - $199,174	-3,878 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $703,255 - $882,316	-13,118 Reduced 77.18%	3,878 $225,000
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $810,539 - $941,408	16,996	16,996 $930,000

Others Institutions Holding ALKS

# of Institutions

395

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.58B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Account

Holocene Advisors, LP Alkermes Plc. Transaction History